Etsuhisa Takahashi
Tokushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Correction: Triethylamine inhibits influenza A virus infection and growth via mechanisms independent of viral neuraminidase and RNA-dependent RNA polymerase.
Journal: PloS one
Published: May 20, 2026
Host-directed antiviral strategy targeting prohibitins: Mel56 suppresses influenza A virus and severe acute respiratory syndrome coronavirus 2 via modulation of antioxidant pathways and mitochondrial function.
Journal: Microbiology spectrum
Published: May 15, 2026
Triethylamine inhibits influenza A virus infection and growth via mechanisms independent of viral neuraminidase and RNA-dependent RNA polymerase.
Journal: PloS one
Published: May 31, 2025
Retraction Note: Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells.
Journal: Scientific reports
Published: May 06, 2025
Protective role of cytosolic prion protein against virus infection in prion-infected cells.
Journal: Journal of virology
Published: August 28, 2024
Bakuchiol targets mitochondrial proteins, prohibitins and voltage-dependent anion channels: New insights into developing antiviral agents.
Journal: The Journal of biological chemistry
Published: August 01, 2023
Anti-influenza Activity of Povidone-Iodine-Integrated Materials.
Journal: Biological & pharmaceutical bulletin
Published: June 26, 2023
Induction of systemic, mucosal, and cellular immunity against SARS-CoV-2 in mice vaccinated by trans-airway with a S1 protein combined with a pulmonary surfactant-derived adjuvant SF-10.
Journal: Influenza and other respiratory viruses
Published: November 08, 2022
Organic synthesis and anti-influenza A virus activity of cyclobakuchiols A, B, C, and D.
Journal: PloS one
Published: September 05, 2020
Last Updated: 09/26/2026